Does RANIBIZUMAB Cause Endophthalmitis? 542 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 542 reports of Endophthalmitis have been filed in association with RANIBIZUMAB (CIMERLI). This represents 3.6% of all adverse event reports for RANIBIZUMAB.
542
Reports of Endophthalmitis with RANIBIZUMAB
3.6%
of all RANIBIZUMAB reports
7
Deaths
95
Hospitalizations
How Dangerous Is Endophthalmitis From RANIBIZUMAB?
Of the 542 reports, 7 (1.3%) resulted in death, 95 (17.5%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Endophthalmitis Listed in the Official Label?
Yes, Endophthalmitis is listed as a known adverse reaction in the official FDA drug label for RANIBIZUMAB.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Endophthalmitis?
AFLIBERCEPT (1,289)
BEVACIZUMAB (903)
DEXAMETHASONE (439)
PREDNISOLONE (217)
TACROLIMUS (200)
PREDNISONE (192)
CALCIUM\MAGNESIUM\POTASSIUM\SODIUM\SODIUM\SODIUM (186)
MOXIFLOXACIN (175)
MYCOPHENOLATE MOFETIL (162)
VANCOMYCIN (141)
Which RANIBIZUMAB Alternatives Have Lower Endophthalmitis Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE